VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1677978
Sex: F
Age:
State: CT

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Fever; Chills; Body aches; Skin pain; Headache; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 12May2021 at 09:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO164) via an unspecified route of administration in the left arm on 20Apr2021 at 07:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 13May2021 at 03:00, the patient experienced fever, chills, body aches, skin pain and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, chills, body aches, skin pain and headache was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677979
Sex: F
Age:
State: VA

Vax Date: 04/13/2021
Onset Date: 05/04/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: My menstrual cycle was delayed for 10 days; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on 13Apr2021 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. The medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. On 04May2021, the patient's menstrual cycle was delayed for 10 days. Therapeutic measures were not taken as a result of the reported event. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event menstrual cycle was delayed for 10 days was resolved on an unknown date in May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677980
Sex: F
Age:
State: GA

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Tiredness; Injection site pain; Headache; Muscle pain; Chills; Joint pain; Fever; Light nausea; Feeling unwell; Arm pain; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0170) via an unspecified route of administration in the right arm on 12May2021 at 12:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure and diabetes. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included triamterene (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), famotidine (MANUFACTURER UNKNOWN) and nitrofurantoin (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received sulfamethoxazole; trimethoprim (BACTRIM) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the right arm on 21Apr2021 at 11:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. On 13May2021 at 02:00, the patient experienced tiredness, injection site pain, headache, muscle pain, chills, joint pain, fever, light nausea, feeling unwell and arm pain. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tiredness, injection site pain, headache, muscle pain, chills, joint pain, fever, light nausea, feeling unwell and arm pain were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRIAMTERENE; METFORMIN; FAMOTIDINE; NITROFURANTOIN

Current Illness:

ID: 1677981
Sex: F
Age:
State: NY

Vax Date: 02/18/2021
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pulsatile Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 18Feb2021 (at the age of 48-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 11Mar2021 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Known allergies was reported as not applicable. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included asthma medication (unspecified) from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced pulsatile tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pulsatile tinnitus was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677982
Sex: F
Age:
State: VA

Vax Date: 03/20/2021
Onset Date: 03/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Injection Site pain; Tiredness; Headache; Muscle Pain; Feeling Unwell; Feeling Feverish (but no fever); This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included ards (acute respiratory distress syndrome) survivor and reactive airways disease. The patient had known allergies to mild latex allergy ((rash/hives). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 21Mar2021 at 01:00, the patient experienced injection site pain, tiredness, headache, muscle pain, feeling unwell and feeling feverish (but no fever). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of events of injection site pain tiredness, headache, muscle pain, feeling unwell and feeling feverish (but no fever) were recovered on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677983
Sex: F
Age:
State:

Vax Date: 04/16/2021
Onset Date: 04/30/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Shingles developed 2 weeks after second vaccine; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 08:00 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 19Mar2021 at 08:00 (at the age of 32-years-old), as a single dose for COVID-19 immunisation. On 30Apr2021, 2 weeks after second vaccine, the patient developed shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the event and which included treatment with unspecified antiviral medication. The clinical outcome of the event shingles developed 2 weeks after second vaccine was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1677984
Sex: F
Age:
State: FL

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Bodyache; Light headed; Chills; Headache; Fever; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 15:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 14Apr2021 at 14:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. On 13May2021 at 06:00, the patient experienced chills, headache, body ache, light headed, fever and nausea. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, headache, body ache, light headed, fever and nausea was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1677985
Sex: F
Age:
State: WA

Vax Date: 04/02/2021
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: New onset latex allergy; This is a spontaneous report from a contactable nurse, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EP6955) in the right arm on 02Apr2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) in the right arm on 23Apr2021 both (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medication was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced new onset latex allergy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event new onset latex allergy was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677986
Sex: F
Age:
State: NY

Vax Date: 01/26/2021
Onset Date: 01/31/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: X-ray; Result Unstructured Data: Test Result:arthritis

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: arthritis; could barely walk; developed terrible joint pain in my shoulders and knees; This is a spontaneous report from a contactable nurse, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 26Jan2021 at 13:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142) via an unspecified route of administration in the left arm on 05Jan2021 at 13:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 31Jan2021 at 15:00, the patient developed terrible joint pain in shoulders and knees to the point where she could barely walk and was diagnosed with arthritis which she never had before. The events lasted roughly four weeks and had subsided almost completely then but it was still not back to normal. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events joint pain in shoulders and knees to the point where she could barely walk and arthritis which included steroid treatment. On an unknown date, the patient underwent X-ray and the result was arthritis. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events joint pain in shoulders and knees to the point where she could barely walk and arthritis was resolved with sequelae on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677987
Sex: M
Age:
State: NY

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Swelling in face, lips, fingers; Warm to touch; Swelling in face, lips, fingers; Swelling in face, lips, fingers; Flush red arms and hands; This is a spontaneous report from a contactable consumer. A 16-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the left arm on 13May2021 at 09:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, chronic urticaria. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included meningococcal vaccine (MANUFACTURER UNKNOWN) and salbutamol (VENTOLIN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 22Apr2021 at 09:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The patient received any other vaccines within four weeks prior to the vaccination. On 13May2021 at 10:00, the patient experienced swelling in face, lips, fingers, flush red arms and hands and warm to touch. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events swelling in face, lips, fingers, flush red arms and hands and warm to touch were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: MENINGOCOCCAL VACCINE; VENTOLIN [SALBUTAMOL]

Current Illness:

ID: 1677988
Sex: F
Age:
State: CA

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Chills; Nausea; Low-grade fever; Headache; Body aches; Injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 11May2021 at 15:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, bipolar disorder, Post-Traumatic Stress Disorder (PTSD) and migraines. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) taken for an unspecified indication from an unknown date. The patient previously took neomycin (MANUFACTURER UNKNOWN) and morphine (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 04Apr2021 at 15:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 08:00, the patient experienced chills, nausea, low-grade fever, headache, body aches and injection site pain. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, nausea, low-grade fever, headache, body aches and injection site pain were resolved on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: IBUPROFEN

Current Illness:

ID: 1677989
Sex: F
Age:
State:

Vax Date: 05/03/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Skin rash, whole body; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 03May2021 at 00:45 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13May2021, ten days after vaccination, the patient experienced skin rash, whole body which was subsidized by taking antihistamine. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of skin rash, whole body which included treatment with antihistamine fexofenadine hydrochloride (ALLEGRA). The clinical outcome of the event skin rash, whole body was resolved on 13May2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677990
Sex: F
Age:
State: CA

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Bad nosebleed; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 12May2021 at 15:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to shellfish allergy and MSG (monosodium glutamate). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included paracetamol (TYLENOL) and goli ashwaganda supplement (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm in Apr2021 at 09:00 (at the age of 42-year-old) as a single dose for COVID-19 immunisation. On 13May2021 at 09:15, the patient experienced bad nosebleed, which required her to leave her desk and seek paper towels in the bathroom. The nosebleed lasted for about 2 minutes. It was also reported that the patient had experienced extremely rarely every experienced nose bleeding throughout her life. The event resulted in emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event nosebleed was resolved on 13May2021 at 09:17, after the duration of 2 minutes. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1677991
Sex: F
Age:
State: MI

Vax Date: 04/22/2021
Onset Date: 05/05/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Headache; Aching joints; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 22Apr2021 at 15:00 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included shellfish allergy (shellfish and crustaceans). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ibuprofen (MOTRIN) from an unknown date for an unknown indication. On 05May2021, two weeks after vaccination, the patient experienced headache and aching joints which was continuing for over a week. Therapeutic measures were not taken as a result of the events headache and aching joints. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache and aching joints were not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the left arm on 13May2021 at 15:00 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: MOTRIN [IBUPROFEN]

Current Illness:

ID: 1677992
Sex: M
Age:
State: NJ

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Fever; Chills; Nausea; Vomiting; Dizziness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 12:00 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 12:45 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 12May2021 at 23:30, the patient experienced fever, chills, nausea, vomiting, dizziness and fatigue. The events did not result in doctors or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of events. The clinical outcome of the events fever, chills, nausea, vomiting, dizziness and fatigue was not resolved at the time of report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1677993
Sex: F
Age:
State: GA

Vax Date: 05/12/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Migraine; Sore throat; General malaise; Muscle aches; Fever; Exhaustion; Bouts of sever chills; This is a spontaneous report from a contactable consumer, the parent. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the left arm on 12May2021 at 12:00 (at the age of 13-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and COVID-19. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 12May2021, the patient experienced sore throat, fever, bouts of severe chills, muscle aches, migraine, exhaustion and general malaise. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, fever, bouts of severe chills, muscle aches, migraine, exhaustion and general malaise was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677994
Sex: F
Age:
State: TX

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Small tender lump over collarbone; Small tender lump over collarbone; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0175) via an unspecified route of administration in the left arm on 11May2021 at 13:15 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Other medical history was not reported. Concomitant medications taken within two weeks of vaccination included paracetamol (TYLENOL) and ibuprofen (ADVIL); both from unknown date for unknown indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Ew0162), via an unspecified route of administration in the right arm on 20Apr2021 at 13:00 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced a small tender lump over collarbone. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event small tender lump over collarbone was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TYLENOL; ADVIL [IBUPROFEN]

Current Illness:

ID: 1677995
Sex: F
Age:
State: TX

Vax Date: 05/13/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Slight pain in left arm; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0162) via an unspecified route of administration in the left arm on 13May2021 at 14:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included protein allergy (Egg protein). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Concomitant medications included hydroxyzine (MANUFACTURER UNKNOWN) and escitalopram oxalate (LEXAPRO) both from an unknown date for an unspecified indication. On 13May2021 at 16:00, the patient experienced slight pain in left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event slight pain in left arm was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: HYDROXYZINE; LEXAPRO

Current Illness:

ID: 1677996
Sex: F
Age:
State: NJ

Vax Date: 05/12/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210513; Test Name: Body temperature; Result Unstructured Data: Test Result:Fever 101; Comments: At 10:00

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Fever to 101; Nausea; Vomiting; This is a spontaneous report from a contactable physician, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 12May2021 at 15:45, as a single dose for COVID-19 immunisation. Medical history included lichen aureus and the patient had allergies to tree nuts, malt barley and dairy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the right arm on 21Apr2021 at 15:45, as a single dose for COVID-19 immunisation. On 13May2021 at 10:00, the patient experienced fever to 101 (unspecified unit), nausea for 1 day, and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with unspecified antipyretic. The clinical outcome of the events fever to 101 and vomiting were recovering at the time of this report. The clinical outcome of the event nausea was recovered on 14May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1677997
Sex: F
Age:
State: MI

Vax Date: 04/25/2021
Onset Date: 04/26/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Itchy rash (Red stripes) over the whole body; Itchy rash (Red stripes) over the whole body; Itchy rash (Red stripes) over the whole body; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left on arm 25Apr2021 at 13:30 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer survivor, ulcerative colitis and allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included mesalazine (MESALAMINE), tamoxifen (MANUFACTURER UNKNOWN) and azathioprine (MANUFACTURER UNKNOWN); all from unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Apr2021 at 12:30, the patient experienced itchy rash (red stripes) over the whole body. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with shot of Benadryl and a shot of prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event itchy rash (red stripes) over the whole body was recovered on unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MESALAMINE; TAMOXIFEN; AZATHIOPRINE

Current Illness:

ID: 1677998
Sex: F
Age:
State: MA

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Pain branching out into my left shoulder; Bit of swelling branching out into my left shoulder and upper chest; Pain branching out into my left shoulder and upper chest; Palpitations occurred during the night, waking me up.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EWO158) via an unspecified route of administration in the left arm on 18Apr2021 at 14:15 (at the age of 45-year-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: WO1832) via an unspecified route of administration in the right arm on 09May2021 at 14:15 (at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and intestinal trouble. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN) and vitamin d nos (VITAMIN D) on an unknown date for unknown indication and unknown if ongoing. On 19Apr2021 at 01:00, on the following night, the patient felt pain and a bit of swelling branching out into her left shoulder and upper chest. Palpitations occurred during the night, waking her up. She took 2 Acetaminophen. It happened again the next night. The branching pain and swelling occurred off and on for about a week, even during the day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with 2 Acetaminophen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events felt pain and a bit of swelling branching out into left shoulder and upper chest and palpitations were resolved on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; AMLODIPINE; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1677999
Sex: M
Age:
State: MA

Vax Date: 05/11/2021
Onset Date: 05/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Swelling of lymph node in the right armpit.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0182) via an unspecified route of administration in the right arm on 11May2021 at 11:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to birch pollen and raw carrots. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0164) via an unspecified route of administration in the right arm on 20Apr2021 at 09:00, as a single dose for COVID-19 immunisation. On 12May2021 at 00:00, the patient experienced swelling of lymph node in the right armpit. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event swelling of lymph node in the right armpit was not recovered at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678000
Sex: F
Age:
State: CO

Vax Date: 05/07/2021
Onset Date: 05/08/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Sore throat; Sinus pressure; Painful eyes; Cough; Chest tightness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration on 07May2021 at 13:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 22:00, the patient experienced sore throat, sinus pressure, painful eyes, cough, chest tightness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore throat, sinus pressure, painful eyes, cough, chest tightness and headache were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678001
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Stinging rash on back of both legs and forearms; Hives on back of armpits.; Uncomfortable and itchy; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 02Apr2021 at 14:30 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021, the patient experienced itch, stinging rash on back of both legs and forearms. The patient also experienced hives on back of armpits. Uncomfortable and itchy. This hives turned into what looked like chicken pox. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of itchy, stinging rash and hives and included treatment with topical steroid. The clinical outcome of the events itchy, stinging rash on back of both legs and forearms (painful rash) and hives on back of armpits were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1678002
Sex: F
Age:
State: MA

Vax Date: 04/18/2021
Onset Date: 04/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Migraine; foggy most of day or all day; Headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the right arm on 18Apr2021 at 10:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 27Mar2021 at 09:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. On 19Apr2021 at 08:00, the patient experienced headache, migraine and was foggy most of the day or all day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, migraine and foggy most of the day or all day were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678003
Sex: F
Age:
State: MD

Vax Date: 05/12/2021
Onset Date: 05/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Visual aura; Splitting migraine; Migraine that prevented from sleeping; Nauseous; Vaccinated arm very painful; Dizzy; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 12May2021 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. On an unknown date in May2021, about 11 hours after the first dose, the patient had a visual aura that lasted over 1.5 hours and a splitting migraine that prevented her from sleeping. She was not prone to nausea but was very nauseous right now (at the time of this report). Her vaccinated arm was very painful and she was dizzy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events visual aura, splitting migraine, migraine that prevented from sleeping, nauseous, vaccinated arm very painful, dizzy were recovering at the time of this report. No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1678004
Sex: F
Age:
State: GA

Vax Date: 04/19/2021
Onset Date: 04/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Axillary adenopathy from second shot on left arm that has last more than 3 weeks; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimoto's disease and gitelman's syndrome. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the right arm on an unknown date, as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021, the patient experienced axillary adenopathy from second shot on left arm that lasted more than 3 weeks, left arm was injection site. The doctor prescribed prednisone to the patient and if adenopathy is not down in one week after steroid, the doctor would order an axillary ultrasound. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with prednisone. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event axillary adenopathy from second shot on left arm that lasted more than 3 weeks was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678005
Sex: F
Age:
State: VA

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Tiredness; Muscle pain; Injection site pain; Feeling unwell; Feeling Feverish (but no fever); This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the right arm on 10Apr2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included reactive airway disease, ARDS (acute respiratory distress syndrome) survivor and mild latex allergy (rash/hives). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. On 10Apr2021 at 18:00, the patient experienced tiredness, muscle pain, injection site pain, feeling unwell and feeling feverish (but no fever). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events tiredness, muscle pain, injection site pain, feeling unwell and feeling feverish (but no fever) were resolved on an unknown date in 2021 at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678006
Sex: F
Age:
State:

Vax Date: 05/19/2021
Onset Date: 05/19/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Throat and mouth lesions; Throat and mouth lesions; This is a spontaneous report received from a non-contactable consumer or other non hcp. A 27-years-old female patient received 1st dose of bnt162b2 (COMIRNATY,Batch/Lot Number: Unknown), via an unspecified route of administration, administered in Arm Left,at the age of 27 years old,on 19May2021 18:15 as Dose 1,single for covid-19 immunization. Medical history included polycystic ovaries from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing Peanuts and tree nuts. Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, start and stop date were not reported.The patient experienced throat and mouth lesions and throat and mouth lesions on 19May2021 18:45.The outcome of the event was recovering.The patient had not received any other vaccine within 4 weeks.The patient received Zoloft as medication within 2 weeks.The patient had not received any treatment for adverse events.The patient had not been diagnosed with covid prior vaccination and not tested post vaccination. No follow-up attempts are possible. Information about lot/batch number cannot be requested. No further information is expected.

Other Meds: ZOLOFT

Current Illness:

ID: 1678007
Sex: F
Age:
State: TX

Vax Date: 05/20/2021
Onset Date: 05/21/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Saturday felt sluggish still had chills and then felt hot and sweaty.; Saturday felt sluggish; then felt hot; Body aches; Headache; Chills; Could not left arm, it was very painful; Fever; Didn't really sleep; Trouble breathing; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN, Patient was 60-year-old and not pregnant at the time of vaccination) via an unspecified route of administration on 20May2021 at 16:00 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide, lisinopril, (MANUFACTURER UNKNOWN) and vitamin D NOS (VITAMIN D); both for unknown indications and since unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21May2021 Friday at 02:30, the patient woke up with headache, body aches, chills, could not lift arm, as it was very painful. The patient reported that a fever broke at around noon that day and had a little trouble breathing. The patient laid in bed all day till the following day and experienced chills a second time, didn't really sleep, and just laid in bed. On Saturday, 22May2021, the patient felt sluggish still had chills and then felt hot, sweaty and her breathing was still affected. On Sunday, 23May2021, the patient felt better with a little bit of activity, but still felt winded. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events trouble breathing, fever, didn't really sleep, body aches, headache, chills, could not lift arm, sweaty, then felt hot and felt sluggish were resolving at the time of this report. Information on lot/batch number has been requested.

Other Meds: LISINOPRIL/HCTZ; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1678008
Sex: M
Age:
State: CA

Vax Date: 04/17/2021
Onset Date: 05/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: lumbar pain; I started to feel skin pain on the area above right kneecap/Skin pain spreaded through the whole body.; nerve pain on the same side of leg; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 28-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration (at the age of 28-years), administered in left arm on 17Apr2021 11:00 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took lutein and experienced known allergies. The facility type of vaccine was reported as public health clinic/veterans administration facility. The patient did not receive any other vaccine in four weeks. Patient does not have covid prior vaccination and has not been tested for covid post vaccination. On 13May2021 at 12:00 (3 Weeks after first covid vaccine shot), I started to feel skin pain on the area above right kneecap/ Skin pain spreaded through the whole body .Then I felt nerve pain on the same side of leg. On 14May2021, experienced I could not sit down as I felt occasional lumbar pain. I even went to orthopedics and they said no trouble found. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome for all the events was reported as recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1678009
Sex: F
Age:
State: WA

Vax Date: 05/26/2021
Onset Date: 05/27/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Extreme pain at injection site; Large red itch welt 18 hours later; Large red itch welt 18 hours later; Fatigue; Stuffy nose; Blurry eyes; Tightness throat; Hoarseness; Sore throat; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26May2021 (at the age of 38-years-old) as dose 1, single for COVID-19 immunization. Medical history included migraine and polycystic ovarian syndrome (PCOS). The patient had known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had not been tested for COVID-19. On 27May2021 at 05:00, the patient experienced extreme pain at injection site, large red itch welt 18 hours later, fatigue, stuffy nose, blurry eyes, tightness/hoarseness/sore throat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events extreme pain at injection site, large red itch welt 18 hours later, fatigue, stuffy nose, blurry eyes, tightness/hoarseness/sore throat was not recovered at the time of this report. The lot number for BNT162b2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1678010
Sex: F
Age:
State: GA

Vax Date: 04/01/2021
Onset Date: 04/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Muscles in upper left arm feels strained/injured Unable to lift anything above 5 lbs without pain; Soreness in upper left arm surrounding the injection site 2 hours after the first shot; Soreness moved around various parts of that arm. Soreness became an aching pain.; Aching pain moved to upper shoulder/base of neck; Aching pain moved to upper shoulder/base of neck; Muscles in upper left arm feels strained/injured Unable to lift anything above 5 lbs without pain; This is a spontaneous from a contactable consumer (patient). A 29-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: ER8737) via an unspecified route of administration, in the left arm on 01Apr2021 (at the age of 29-years-old) as dose 1, single and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0170) via an unspecified route of administration, in the left arm on 29Apr2021 as dose 2, single both for covid-19 immunisation. Facility where the most recent COVID-19 vaccine was administered was other. Medical history included covid-19 from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. Prior to vaccination patient was diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. The patient did not receive any vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced soreness in upper left arm surrounding the injection site 2 hours after the first shot. Soreness moved around various parts of that arm. Soreness became an aching pain. Aching pain moved to upper shoulder/base of neck. Muscles in upper left arm feels strained/injured. Unable to lift anything above 5 lbs without pain. Seriousness criteria reported as no. The patient did not receive treatment for the events. Outcome of the events was not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678011
Sex: F
Age:
State: MO

Vax Date: 04/29/2021
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Brain fog/A disconnect with my arms and legs; Arm pain; Horrible joint/lymph gland pain; Horrible joint/lymph gland pain; Feeling of small needles poking me in the head; Fatigue; This is a spontaneous report from a contactable consumer (patient). A 55-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EW0170), via an unspecified route of administration in right arm on 29Apr2021 at 13:15 (at the age of 55-year-old) as dose 1, single for COVID-19 immunisation. Medical history included hypoglycemia from an unknown date and unknown if ongoing, splenic hemangiomas from an unknown date and unknown if ongoing, peanuts bother me from an unknown date and unknown if ongoing, hypersensitive to meds from an unknown date and unknown if ongoing. Concomitant medications included paracetamol (TYLENOL) taken for an unspecified indication, start and stop date were not reported; Oil of oreganol taken for an unspecified indication, start and stop date were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, after first vaccination, the patient experienced some brain fog, arm pain, horrible joint/lymph gland pain, feeling of small needles poking me in the head, a disconnect with my arms and legs and fatigue. This lasted about 4 days. The seriousness of the events was reported as non-serious. The patient did not receive any treatment for the events. The outcome of the events was reported as resolved on an unknown date. Follow-up attempts are completed. No further information is expected.

Other Meds: TYLENOL

Current Illness:

ID: 1678012
Sex: F
Age:
State: NH

Vax Date: 06/05/2021
Onset Date: 06/06/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Body aches; Fever; Dizziness; This is a spontaneous report from a contactable consumer. A 15-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), intramuscularly administered in right arm on 05Jun2021 at 11:15 (at the age of 15 years old) as dose 2, single for COVID-19 immunisation. No medical history was reported. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162B2 (Lot Number: unknown), intramuscularly administered in the right arm on 15May2021 at 11:15 (at the age of 15-years-old) as dose 1, single dose for COVID-19 immunisation. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the vaccination and did not receive any other medications within 2 weeks prior to the vaccination. On 06Jun2021 at 00:00, about 18 hours after vaccination (as reported, possible discrepant), the patient experienced body aches, fever and dizziness. The events did not result in doctor or other healthcare professional office or clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of events, body aches, fever and dizziness which included treatment with paracetamol (TYLENOL) and ibuprofen (ADVIL). Outcome of all events was recovering. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1678013
Sex: F
Age:
State: MT

Vax Date: 06/01/2021
Onset Date: 06/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: My neck got stiff on the right side; slight headache; dizziness; face turned red got very hot; face turned red got very hot; the right side of my face went numb; Facial flushing; vasodilation 15 min after administration; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 61-years-old non-pregnant female patient received first dose of bnt162b2 (Pfizer covid 19 vaccine, formulation: solution for injection, Batch/Lot Number: Fr8731), via intramuscular route of administration, administered in Arm Right on 01Jun2021 10:00 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included fibromyalgia, arthropod sting from an unknown date and unknown if ongoing known allergies Bee stings, drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Sulfa, back pain from an unknown date and unknown if ongoing other medical history chronic back pain. Concomitant medications included cetirizine hydrochloride; asa (ASA). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 01Jun2021 10:15, the patient experienced my neck got stiff on the right side, slight headache, dizziness, face turned red got very hot, face turned red got very hot, the right side of my face went numb, facial flushing, vasodilation 15 min after administration. The outcome of the evens was not recovered. Follow-up attempts completed. No further information expected.

Other Meds: ZYRTECNO; ASA

Current Illness:

ID: 1678014
Sex: F
Age:
State: NC

Vax Date: 05/26/2021
Onset Date: 05/26/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Altered me natural cycle; late period; This is a spontaneous report from a contactable consumer (patient). A 24-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number and expiration date were not reported), via unspecified route of administration in the left arm on 26May2021 at 12:00 (at the age of 24-years-old) as dose 2, single for COVID-19 immunisation at a pharmacy or drugstore. The patient has no relevant medical history and no concomitant medications. The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in the left arm on an unspecified date as dose 1, single for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021, the patient experienced altered menstrual (reported as me natural) cycle and late period. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1678015
Sex: F
Age:
State: NY

Vax Date: 05/14/2021
Onset Date: 05/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Have not gotten her monthly menstrual cycle; This is a spontaneous report from a non-contactable consumer (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number and Expiration Date: not reported), via an unspecified route of administration, administered in left arm on 14May2021 at 16:00 (at the age of 32 years old) as dose number unknown, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient was not pregnant at time of vaccination and prior to vaccination the patient was not diagnosed with COVID-19. The patient did not receive other vaccine in four weeks. On 14May2021, the patient reported that she have not gotten her monthly menstrual cycle. The event resulted in doctor or other healthcare professional office/clinic visit. No treatment was given in response to the event. The patient underwent lab tests/ COVID test after vaccination which included nasal swab with a negative result on an unspecified date. Outcome of the event was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1678016
Sex: F
Age:
State: OH

Vax Date: 05/21/2021
Onset Date: 06/02/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Menstrual cycle is more than a week late; This is a spontaneous report from a contactable consumer (patient). A 14-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 21May2021 at 13:00 (at the age of 14-years-old) (Batch/Lot number was not reported) as dose1, single for COVID-19 immunisation. Medical history included MDD (major depressive disorder), SAD (seasonal affective disorder), and GERD (gastrooesophageal reflux disease). The patient was not pregnant at the time of the event. The patient has known allergies to amoxicillin, lamyctil, and adhesives. Concomitant medications included sertraline hydrochloride (ZOLOFT), dexmethylphenidate hydrochloride (FOCALIN), cyproheptadine, and trazodone. The patient did not receive other vaccine in four weeks. Zoloft, focalin, cyproheptadine, and trazodone were received in two weeks. The patient did not have COVID-19 prior to vaccination and had not been tested for COVID-19 post-vaccination. On 02Jun2021, the patient experienced menstrual cycle is more than a week late. No treatment was received for the event. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ZOLOFT; FOCALIN [DEXMETHYLPHENIDATE HYDROCHLORIDE]; CYPROHEPTADINE; TRAZODONE

Current Illness:

ID: 1678017
Sex: F
Age:
State: NC

Vax Date: 06/12/2021
Onset Date: 06/13/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: swelling in right armpit; tissue in right armpit seems to be hard and hurts to touch; This is a spontaneous report from a contactable consumer or other non-HCP reported about herself. A 49-year-old non-pregnant female patient received second dose of bnt162b2 (BNT162B2; Solution for injection; Lot number: UNKNOWN), via an unspecified route of administration, administered in right arm as dose 2, single on 12Jun2021 (at the age of 49-year-old) for covid-19 immunisation. The patient's medical history included allergies with amoxicillin, vicodin drugs and with pollen extracts. Historical vaccine included first dose of bnt162b2 (BNT162B2; Solution for injection; Lot number: EW0186), via an unspecified route of administration, administered in right arm as dose 1, single on 22May2021 09:15 AM (at the age of 49-year-old) for covid-19 immunisation. And the patient took another second dose of unspecified Pfizer vaccine (Lot number: EW0167) via unspecified route of administration, administered in right arm on 22May2021. Concomitant medications included labetalol, losartan and hydrochloorthiazide all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and received other medications labetalol, losartan and hydrochlorothiazide within 2 weeks of vaccination. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. On 13Jun2021, the next day after the second dose of vaccine patient experienced there was swelling and tissue in right armpit seemed to be hard and hurts to touch. At the time of this report, outcome of events was unknown. Information on the lot/ batch number has been requested. Follow-up attempts are completed. No further information is expected.

Other Meds: LABETALOL; LOSARTAN; HYDROCHLOORTHIAZIDE

Current Illness:

ID: 1678018
Sex: F
Age:
State: NC

Vax Date: 02/11/2021
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: broke out in spots that are red and raised like pumped up on her belly; her skin is turning red; itch on the spots; This is a spontaneous report received from a contactable consumer (patient's husband). A 77-year old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/lot number: EM9810; Expiration date were not reported), via an unspecified route of administration in the right arm on 11Feb2021 16:00 (at the age of 77-years-old) as dose 2, single for COVID-19 immunization at a clinic. Medical history included allergy to shellfish from an unknown date and unknown if ongoing. The patient has no concomitant medications. The patient was previously vaccinated with BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/lot number: EL3246) via an unspecified route of administration in the right arm on 21Jan2021 16:00 (at the age of 76 years-old) as dose 1, single for COVID-19 immunisation and experienced broke out in spots that are red and raised (that were like little bites, like welts that stay for two or three days and then they go down). No other vaccine was received by the patient in four weeks. On an unspecified date after the second dose, the patient broke out in spots that are red and raised like pumped up on her belly and her skin was turning red and itch on the spots. Events resulted in a physician (dermatologist) office visit. Treatment with a cream and rubbing alcohol were taken for the events. The outcome of the events was not recovered. The reporter was querying if the events were normal and how long will the events last. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678019
Sex: M
Age:
State: FL

Vax Date: 06/14/2021
Onset Date: 06/15/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Rash ( looks like chickenpox ) on both arms and especially hands on inside palms; Rash ( looks like chickenpox ) on both arms and especially hands on inside palms; This is a spontaneous report from a contactable consumer reported that :A 14-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 14Jun2021 12:30 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization(Age at vaccination 14 years). The patient medical history was not reported. Concomitant medication(s) included amoxicillin, clavulanate potassium 875-125 mg taken for an unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. There were no allergies reported. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. The patient experienced rash (looks like chickenpox) on both arms and especially hands on inside palms on 15Jun2021 08:00. No treatment was reported. The event outcome was Not recovered.

Other Meds: AMOXICILINA CLAV [AMOXICILLIN;CLAVULANATE POTASSIUM]

Current Illness:

ID: 1678020
Sex: F
Age:
State: NC

Vax Date: 06/10/2021
Onset Date: 06/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Swollen lymph nodes in the area between my neck and my left shoulder/swollen lymph nodes in my left armpit/swollen lymph nodes in my left breast/swollen lymph nodes in my left groin.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 50-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EW0176), via an unspecified route of administration, administered in Left arm on 10Jun2021 08:30 at the age of 50-years-old as dose 2, single for covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. The patient previously took morphine, benzoyl peroxide and experienced allergy. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: ER8736), via an unspecified route of administration, administered in Left arm on 20May2021 08:30 at the age of 50-years-old as dose 1, single for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient did not receive other medications in two weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. On 12Jun2021 at 07:00, the patient experienced Swollen lymph nodes in the area between my neck and my left shoulder; swollen lymph nodes in my left armpit; swollen lymph nodes in my left breast, swollen lymph nodes in my left groin. Adverse event resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for adverse event. The outcome of event, Swollen lymph nodes in the area between my neck and my left shoulder; swollen lymph nodes in my left armpit; swollen lymph nodes in my left breast, swollen lymph nodes in my left groin was not recovered. Follow-Up (26Jul2021): Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1678021
Sex: F
Age:
State: FL

Vax Date: 06/14/2021
Onset Date: 06/14/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: I am experiencing bone and joint pain. The effects are concentrated in my knees.; I am experiencing bone and joint pain. The effects are concentrated in my knees.; I am experiencing bone and joint pain. The effects are concentrated in my knees.; This is a spontaneous report from a contactable consumer. This 48-year-old non-pregnant female consumer (patient) reported that she received dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: GW0183) via an unspecified route of administration on 14Jun2021 (at 48-year-old) on left arm as dose number unknown, single for COVID-19 immunization. The patient had no medical history and no allergies. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since the vaccination. The patient's concomitant medications were not reported. It was mentioned that patient was not pregnant at the time of vaccination, she did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. On 14Jun2021 at 04:30 PM the patient experienced bone and joint pain. The effects are concentrated in her knees. No treatment was received for the events..The patient had not recovered. The device Date was 21Jun2021 Follow-up attempts were completed. No further information was expected.

Other Meds:

Current Illness:

ID: 1678022
Sex: M
Age:
State: PA

Vax Date: 06/12/2021
Onset Date: 06/12/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210626; Test Name: TSH; Result Unstructured Data: Test Result:2.8, Normal; Comments: Units: 2.8; Test Date: 20210621; Test Name: CXR; Result Unstructured Data: Test Result:RBBB, Normal; Comments: in ER; Test Date: 20210708; Test Name: Echo; Result Unstructured Data: Test Result:Normal; Test Date: 2021; Test Name: Electrocardiogram (EKG); Result Unstructured Data: Test Result:Unknown results; Test Date: 20210620; Test Name: Electrocardiogram (EKG); Result Unstructured Data: Test Result:NSR incomplete; Comments: in ER; Test Date: 2021; Test Name: Troponin level test; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: X-rays; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Vomiting

Symptoms: Minor chest pains were felt; Shortness of breath; This is a spontaneous report from a from a contactable physician and from contactable consumer (patient reported for himself). A 36-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection) via intramuscular route of administration, administered in Arm Left on 12Jun2021 at 10:30 am (Batch/Lot Number: EW0179) as dose 1, single for covid-19 immunization (at the age of 36-years-old). Medical history included ongoing slightly elevated high blood pressure and anxiety from an unknown date. Concomitant medication(s) included bisoprolol fumarate (BISOPROLOL FUMARATE, 5 mg) taken for slightly elevated high blood pressure from 29May2021 and ongoing. Facility where the most recent COVID-19 vaccine was administered was reported as pharmacy or drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient had no known allergies. It was reported by the patient that within hours of receiving first dose of vaccine on 12Jun2021 at 16:30 pm the minor chest pains were felt and these continued sporadically, about twice a day, for several days, along with occasional shortness of breath. One week after receiving the first dose, the chest pains became more frequent, five to six times a day. this increased frequency continues through the date this report was being filed 23Jun2021. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. After that the physician reported the laboratory test results and physician considered that the Pfizer product had a causal effect to the adverse event. Therapeutic measures were taken as a result of adverse events. The patient underwent lab tests and procedures which included TSH (blood thyroid stimulating hormone) which result showed units 2.8, normal on 26Jun2021, CXR (chest x-ray) which showed RBBB, normal in ER (emergency room) on 21Jun2021, Echo (echocardiogram) which was normal on 08Jul2021, EKG (electrocardiogram) had unknown results on an unspecified date in 2021 and showed NSR incomplete on 20Jun2021 in emergency room, Troponin level test (troponin) and X-ray which had unknown results on an unspecified date in 2021. The outcome of the events was unknown. The Physician considered that the Pfizer product had a related causal effect to the adverse event. Follow-up attempts are completed. No further information is expected.

Other Meds: BISOPROLOL FUMARATE

Current Illness: Anxiety; Elevated BP (Taking Bisoprolol Fumarate 5mg for slightly elevated high blood pressure. Began medication 29May2021)

ID: 1678023
Sex: F
Age:
State:

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: felt like someone was sitting on her chest; the patient developed chills; stated she 'felt like someone was sitting on her chest' (PT Chest pain); This is a spontaneous report from a non-contactable pharmacist. A 32-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number and Expiration date was not reported, Age group: Adult 18-64 Years), dose 2 via an unspecified route of administration on Jan2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on Jan2021 as dose 1, single for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Jan2021 the patient experienced Several hours after the 2nd dose of the covid-19 vaccine, felt like someone was sitting on her chest, the patient developed chills, stated she 'felt like someone was sitting on her chest' (PT: chest pain). The patient took acetaminophen for treatment. The events resolved by the next morning. The outcome of event was recovered on Jan2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1678024
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: eye pressure is rising; This is a spontaneous report from a sponsored program. A contactable consumer (patient) reported that a 70 year old female patient started to receive exemestane (AROMASIN, Coated tablet, strength: 25 mg) via unknown route of administration from an unknown date at an unknown dose and frequency for Malignant neoplasm of unspecified site of right female breast and bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via unknown route of administration on an unknown date as dose number unknown, single for COVID-19 immunisation. The patients medical history and concomitant medications were not reported. Patient stated her eye pressure was rising. Also, stated she had received the Pfizer Covid shot and is very happy so far. The action taken in response to the event with exemestane was unknown. The outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1678025
Sex: F
Age:
State: CA

Vax Date: 06/25/2021
Onset Date: 06/27/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210616; Test Name: Covid-19; Test Result: Negative

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: 3 red bumps around my mouth; it is an acne break out; feeling extremely fatigued and slept most of the day; feeling extremely fatigued and slept most of the day; This is a spontaneous report from a contactable consumer (patient). A 36-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EW0181), via an unspecified route of administration, on 25Jun2021 at 05:45 PM (at the age of 36-year-old), as dose 1, single for COVID-19 immunization. Patient's medical history included gastrooesophageal reflux disease from an unknown date and unknown if ongoing, hypersensitivity from an unknown date and unknown if ongoing. Patient's had allergies to red and purple tattoo ink. Concomitant medications included lynestrenol taken for an unspecified indication, start and stop date were not reported. On 27Jun2021 (day 3) the patient experienced feeling extremely fatigued and slept most of the day, on 02Jul2021 (day 8) 3 red bumps around my mouth, On day 13 the red bumps spread all over my face, it is an acne. On 16Jun2021 the patient underwent lab tests and procedures which included sars-cov-2 test and the result was negative. Patient was received Antihistimine and topical ointment treatment. Outcome of all events were not recovered. Follow-up attempts are completed. No further information is expected.

Other Meds: LYNESTRENOL

Current Illness:

ID: 1678026
Sex: F
Age:
State: NY

Vax Date: 06/17/2021
Onset Date: 06/18/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: was supposed to get her period around the same day as her 2nd vaccine (17Jun2021) it is now 12Jul2021 and she has still not gotten it; This is a spontaneous report from a contactable consumer, the patient. A 14-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0185), via an unspecified route of administration in the arm left on 17Jun2021 17:00 as dose 2, single (at the age of 14-years old) for covid-19 immunization. Medical history included ongoing asthma and allergies to penicillin family. Concomitant medications included montelukast sodium (SINGULAIR), beclometasone dipropionate (QVAR), clarithromycin (CLARITIN), allergy nasal spray and vit. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: EW0185), via an unspecified route of administration in the arm left on 27May2021 17:15 as dose 1, single (at the age of 14-years old) for covid-19 immunization. On 18Jun2021, the patient was supposed to get her period around the same day as her 2nd vaccine (17Jun2021) it was now 12Jul2021 and she had still not gotten it. The patient visited the doctor or other healthcare professional office/clinic for the events. The patient did not receive any treatment for the events. The patient did not receive any other vaccine in four weeks. The patient had not covid prior to the vaccination and the patient had not tested for covid post vaccination. The outcome of the event was not recovered. Follow-up attempts were completed. No further information was expected.

Other Meds: SINGULAIR; QVAR; CLARITIN [CLARITHROMYCIN]

Current Illness: Asthma

ID: 1678027
Sex: F
Age:
State: WA

Vax Date: 05/01/2021
Onset Date: 05/04/2021
Rec V Date: 09/07/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Vaginal bleeding after first dose; This is a spontaneous report from a non-contactable consumer or other non hcp. A 60-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), via an unspecified route of administration, administered in Arm Left on 01May2021 13:00 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. Medical history included thyroid disorder from an unknown date and unknown if ongoing Other medical history: Thyroid. Concomitant medications included modafinil (MODAFINIL) duloxetine hydrochloride (CYMBALTA) taken for an unspecified indication, start and stop date were not reported. The patient previously took indomethacin [indometacin] and experienced drug hypersensitivity, zoloft and experienced drug hypersensitivity. On 04May2021, the patient experienced vaginal bleeding after first dose. Outcome of events was recovered on unspecified date of 2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: MODAFINIL; CYMBALTA

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am